These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 28756277

  • 1. New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors.
    Iqbal S, Khan MA, Javaid K, Sadiq R, Fazal-Ur-Rehman S, Choudhary MI, Basha FZ.
    Bioorg Chem; 2017 Oct; 74():72-81. PubMed ID: 28756277
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G, Peng Z, Wang J, Li X, Li J.
    Eur J Med Chem; 2017 Jan 05; 125():423-429. PubMed ID: 27689725
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
    Wang G, Wang J, He D, Li X, Li J, Peng Z.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2806-2809. PubMed ID: 27177827
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar 15; 83():161-169. PubMed ID: 30366316
    [Abstract] [Full Text] [Related]

  • 5. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA, Javaid K, Wadood A, Jamal A, Batool F, Fazal-Ur-Rehman S, Basha FZ, Choudhary MI.
    Med Chem; 2017 Mar 15; 13(7):698-704. PubMed ID: 28745232
    [Abstract] [Full Text] [Related]

  • 6. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS, Mohammadi-Khanaposhtani M, Kiani M, Ranjbar PR, Zabihi E, Pourbagher R, Rahimi R, Faramarzi MA, Biglar M, Larijani B, Mahdavi M, Hamedifar H, Hajimiri MH.
    Bioorg Chem; 2019 Nov 15; 92():103206. PubMed ID: 31445191
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G, Peng Z, Wang J, Li J, Li X.
    Bioorg Med Chem Lett; 2016 Dec 01; 26(23):5719-5723. PubMed ID: 27810241
    [Abstract] [Full Text] [Related]

  • 8. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.
    Luo S, Zhao L, Peng H, Peng Z, Wang G.
    Eur J Med Chem; 2024 Sep 05; 275():116600. PubMed ID: 38889608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and In Vitro Inhibition of α-Glucosidase Enzyme.
    Bashir MA, Javaid K, Shaikh M, Choudhary MI, Siddiqui H.
    Med Chem; 2020 Sep 05; 16(8):1124-1135. PubMed ID: 32003674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E, Mohammadi-Khanaposhtani M, Rezaei S, Sarrafi Y, Sharafi Z, Samadi N, Faramarzi MA, Bandarian F, Hamedifar H, Larijani B, Hajimiri M, Mahdavi M.
    Arch Pharm (Weinheim); 2019 Aug 05; 352(8):e1900034. PubMed ID: 31330079
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents.
    Sayahi MH, Zareei S, Halimi M, Alikhani M, Moazzam A, Mohammadi-Khanaposhtani M, Mojtabavi S, Faramarzi MA, Rastegar H, Taslimi P, Ibrahim EH, Ghramh HA, Larijani B, Mahdavi M.
    Sci Rep; 2024 Jul 09; 14(1):15791. PubMed ID: 38982268
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors.
    Shareghi-Boroujeni D, Iraji A, Mojtabavi S, Faramarzi MA, Akbarzadeh T, Saeedi M.
    Bioorg Chem; 2021 Jun 09; 111():104869. PubMed ID: 33839583
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors.
    Jabeen F, Shehzadi SA, Fatmi MQ, Shaheen S, Iqbal L, Afza N, Panda SS, Ansari FL.
    Bioorg Med Chem Lett; 2016 Feb 01; 26(3):1029-1038. PubMed ID: 26725952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.